| 產(chǎn)品編號(hào) | bs-2942R |
| 英文名稱(chēng) | HHV8 ORF K14 Rabbit pAb |
| 中文名稱(chēng) | 人類(lèi)皰疹病毒8 ORF14抗體 |
| 別 名 | K14 protein; Human herpesvirus 8(HHV-8)(Kaposi's sarcoma-associated herpesvirus); |
| 研究領(lǐng)域 | 免疫學(xué) 細(xì)菌及病毒 |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | (predicted: HHV 8 type M) |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 38 kDa |
| 檢測(cè)分子量 | |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human HHV8/ORF K14: 111-210/348 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Database links:
SwissProt: O40948 HHV-8 Entrez Gene: 4961465 HHV-8
學(xué)者研究認(rèn)為：包括HHV-8在內(nèi)的一類(lèi)皰疹病毒THC（Herpesviruses）都存在ORF50基因的誘導(dǎo)，ORF50能夠靶向這類(lèi)病毒。 |
